Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09FAD
|
|||
| Former ID |
DNC009101
|
|||
| Drug Name |
N-isobutyl-2-oxo-2H-chromene-3-carboxamide
|
|||
| Synonyms |
N-isobutyl-2-oxo-2H-chromene-3-carboxamide; AC1LGLK5; 3-carboxamido coumarin, 3; Oprea1_019533; CHEMBL512883; BDBM29154; MolPort-002-807-315; HMS1722A09; ZINC341401; AKOS001056674; MCULE-2251500223; 1846-84-0; ST50811140; N-(2-methylpropyl)-2-oxochromene-3-carboxamide; SR-01000051779; AG-670/14532137; N-(2-methylpropyl)(2-oxochromen-3-yl)carboxamide; SR-01000051779-1; N-(2-methylpropyl)-2-oxo-2H-chromene-3-carboxamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H15NO3
|
|||
| Canonical SMILES |
CC(C)CNC(=O)C1=CC2=CC=CC=C2OC1=O
|
|||
| InChI |
1S/C14H15NO3/c1-9(2)8-15-13(16)11-7-10-5-3-4-6-12(10)18-14(11)17/h3-7,9H,8H2,1-2H3,(H,15,16)
|
|||
| InChIKey |
BKVFDOZWDVAMFZ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Monoamine oxidase type B (MAO-B) | Target Info | Inhibitor | [1] |
| BioCyc | Superpathway of tryptophan utilization | |||
| Tryptophan degradation via tryptamine | ||||
| Dopamine degradation | ||||
| Putrescine degradation III | ||||
| Noradrenaline and adrenaline degradation | ||||
| KEGG Pathway | Glycine, serine and threonine metabolism | |||
| Arginine and proline metabolism | ||||
| Histidine metabolism | ||||
| Tyrosine metabolism | ||||
| Phenylalanine metabolism | ||||
| Tryptophan metabolism | ||||
| Drug metabolism - cytochrome P450 | ||||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Dopaminergic synapse | ||||
| Cocaine addiction | ||||
| Amphetamine addiction | ||||
| Alcoholism | ||||
| Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
| 5-Hydroxytryptamine degredation | ||||
| Dopamine receptor mediated signaling pathway | ||||
| Pathway Interaction Database | Alpha-synuclein signaling | |||
| WikiPathways | Tryptophan metabolism | |||
| Dopamine metabolism | ||||
| Phase 1 - Functionalization of compounds | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem. 2009 Apr 9;52(7):1935-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.